Stock Rich List
Nasdaq: PTCT

PTC Therapeutics insiders

The officers, directors and 10% owners of PTC Therapeutics, Inc. who hold the most stock, valued at the live PTCT price.

$58.33
PTCT today −$1.9M (−3.16%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
5
Their PTCT stock
$55.5M
Market value
$4.87B
Held by ranked insiders
1.14%

Insiders by value of PTCT holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Matthew B. KleinCHIEF EXECUTIVE OFFICER383,868$22.4M0.46%4708th
2Stuart Walter PeltzCHIEF EXECUTIVE OFFICER260,593$15.2M0.31%6374th
3Michael SchmertzlerDirector163,266$9.5M0.20%2218th
4Mark Elliott BouldingEXEC. VP AND CLO105,272$6.1M0.13%12562nd
5Emily Luisa HillCHIEF FINANCIAL OFFICER38,925$2.3M<0.1%12564th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for PTC Therapeutics; see each profile for the filing.